Linlin Luo

1.2k total citations
49 papers, 762 citations indexed

About

Linlin Luo is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Linlin Luo has authored 49 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Linlin Luo's work include Biosimilars and Bioanalytical Methods (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Linlin Luo is often cited by papers focused on Biosimilars and Bioanalytical Methods (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Linlin Luo collaborates with scholars based in China, United States and United Kingdom. Linlin Luo's co-authors include Chun Peng, Burton B. Yang, Geeta Upadhyay, Subha Madhavan, Rakesh Kumar, Yuriy Gusev, Lubna Nadeem, Caroline Dunk, Guodong Fu and Stephen J. Lye and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Analytical Chemistry.

In The Last Decade

Linlin Luo

42 papers receiving 743 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linlin Luo China 13 369 261 185 151 97 49 762
Daniel Guimarães Tiezzi Brazil 17 267 0.7× 290 1.1× 281 1.5× 488 3.2× 86 0.9× 77 1.1k
M. Amneus United States 10 354 1.0× 245 0.9× 78 0.4× 139 0.9× 125 1.3× 18 854
Nobuhisa Yoshikawa Japan 18 266 0.7× 145 0.6× 146 0.8× 253 1.7× 209 2.2× 91 980
Gloria Marquina Spain 10 294 0.8× 89 0.3× 120 0.6× 127 0.8× 39 0.4× 32 499
Nana Tchabo United States 14 326 0.9× 190 0.7× 107 0.6× 235 1.6× 133 1.4× 25 744
Laure Favier France 16 328 0.9× 172 0.7× 193 1.0× 573 3.8× 70 0.7× 61 1.0k
Yoshimichi Tanaka Japan 16 350 0.9× 194 0.7× 87 0.5× 269 1.8× 198 2.0× 45 850
Lesley Lomo United States 15 206 0.6× 133 0.5× 185 1.0× 232 1.5× 92 0.9× 27 707
Shelly Seward United States 15 298 0.8× 157 0.6× 59 0.3× 390 2.6× 121 1.2× 34 898
Katherine Karakasis Canada 15 397 1.1× 215 0.8× 99 0.5× 494 3.3× 80 0.8× 44 1.0k

Countries citing papers authored by Linlin Luo

Since Specialization
Citations

This map shows the geographic impact of Linlin Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linlin Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linlin Luo more than expected).

Fields of papers citing papers by Linlin Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linlin Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linlin Luo. The network helps show where Linlin Luo may publish in the future.

Co-authorship network of co-authors of Linlin Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Linlin Luo. A scholar is included among the top collaborators of Linlin Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linlin Luo. Linlin Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Grimaldi, Christine, Susan Richards, Daniel Baltrukonis, et al.. (2025). IQ Survey Results on Current Industry Practices—Part 1: Immunogenicity Risk Assessment. Clinical Pharmacology & Therapeutics. 117(6). 1596–1604.
4.
Liang, Chao, Linlin Luo, Qi Xie, et al.. (2025). Diversification and evolution of serine/arginine‐rich splicing factors in plants. The Plant Journal. 121(4). e70004–e70004.
5.
6.
Luo, Linlin & Jie Yu. (2024). Identifying core genes in sepsis by LASSO regression and SVM-RFE algorithm. Archives of Medical Science.
7.
8.
Zhu, Jin Liang, Linlin Luo, Song Yue, et al.. (2022). Gender-Specific Related Factors for Suicidal Ideation During COVID-19 Pandemic Lockdown Among 5,175 Chinese Adolescents. Frontiers in Public Health. 10. 810101–810101. 7 indexed citations
9.
10.
Liu, Changhai, et al.. (2021). Hierarchical molybdenum-doped NiCoP@carbon microspheres: a highly-efficient electrocatalyst for the hydrogen evolution reaction. Chemical Communications. 57(77). 9846–9849. 11 indexed citations
11.
Moore, Kevin, Khurram Jamil, Linlin Luo, et al.. (2020). Real‐world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome. Alimentary Pharmacology & Therapeutics. 52(2). 351–358. 23 indexed citations
12.
Penrod, John R., et al.. (2020). <p>Costs and Cost Drivers Associated with Non-Small-Cell Lung Cancer Patients Who Received Two or More Lines of Therapy in Europe</p>. ClinicoEconomics and Outcomes Research. Volume 12. 23–33. 13 indexed citations
13.
Shah, Ruchit, Marc Botteman, Caitlyn T. Solem, et al.. (2019). A Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma (aRCC). Clinical Genitourinary Cancer. 17(5). 356–365.e1. 11 indexed citations
14.
Luo, Linlin, et al.. (2019). <p>Risks of budesonide/formoterol for the treatment of stable COPD: a meta-analysis</p>. International Journal of COPD. Volume 14. 757–766. 3 indexed citations
15.
16.
17.
Solem, Caitlyn T., et al.. (2017). Cost Drivers of Lung Cancer Care: Results From A Retrospective Chart Review of Pretreated Advanced Nsclc Patients in Europe. Value in Health. 20(9). A431–A432. 1 indexed citations
18.
Luo, Linlin, Noriko Steiner, Yuriy Gusev, et al.. (2016). Ly6E/K Signaling to TGFβ Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance. Cancer Research. 76(11). 3376–3386. 79 indexed citations
19.
Jiang, Hao, Jianing Zeng, Craig Titsch, et al.. (2013). Fully Validated LC-MS/MS Assay for the Simultaneous Quantitation of Coadministered Therapeutic Antibodies in Cynomolgus Monkey Serum. Analytical Chemistry. 85(20). 9859–9867. 64 indexed citations
20.
Luo, Linlin, Gang Ye, Lubna Nadeem, et al.. (2012). MicroRNA-378a-5p promotes trophoblast cell survival, migration and invasion by targeting Nodal. Journal of Cell Science. 125(Pt 13). 3124–32. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Guimarães Tiezzi Breakdown of academic impact, for papers by M. Amneus Breakdown of academic impact, for papers by Nobuhisa Yoshikawa Breakdown of academic impact, for papers by Gloria Marquina Breakdown of academic impact, for papers by Nana Tchabo Breakdown of academic impact, for papers by Laure Favier Breakdown of academic impact, for papers by Yoshimichi Tanaka Breakdown of academic impact, for papers by Lesley Lomo Breakdown of academic impact, for papers by Shelly Seward Breakdown of academic impact, for papers by Katherine Karakasis
Rankless by CCL
2026